Posted on May 13, 20205/13/20
Minnesota to Require Drugmakers to Justify Price Hikes
Posted on May 13, 20205/13/20
Zolgensma Proposed to Cost 167 Million Yen in Japan
Posted on May 12, 20205/12/20
Italy’s Oncological Association Seeks to Reduce Cost of CAR-T Cells
Posted on May 12, 20205/12/20
EMA Recommends Expanded Remdesivir Compassionate Use Scheme
Posted on May 11, 20205/11/20
FDA OK’s AZ & Merck’s Lynparza Plus Bevacizumab in HRD-Positive Ovarian Cancer
Posted on May 6, 20205/6/20
Biosimilars Saved Spain 2,400 Million Euros Between 2009 and 2020
Posted on May 6, 20205/6/20
Brazil in Talks to Gain Access to Gilead’s Remdesivir
Posted on May 4, 20205/4/20
UK National Clinical Trial Initiative Could Fast-Track COVID-19 Treatments
Posted on May 4, 20205/4/20
Pricentric Insights: China’s Interim Measures for NRDL, BMI Administration
Posted on April 28, 20204/28/20